Summarize with:
Ahmedabad: The potential COVID-19 vaccine locally developed by Ahmedabad-based Zydus Cadila Healthcare got nod from the Drugs Controller General of India (DCGI) on Thursday for human clinical trials, as per the media reports.
The approval process was fast-tracked following recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic.
It is to be noted that recently the country’s ‘first’ indigenous COVID-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology (NIV), had got the nod for human clinical trials from the DCGI.
Summarize with:
